Alpha And Omega Medicals (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.50 M
as on 16-12-2024
- Company Age 28 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue -20.57%
(FY 2019)
- Profit -26.94%
(FY 2019)
- Ebitda -24.75%
(FY 2019)
- Net Worth 13.63%
(FY 2019)
- Total Assets 12.20%
(FY 2019)
About Alpha And Omega Medicals (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sudha Berlia, Rajendrakumar Padia, and Rashmi Padia serve as directors at the Company.
- CIN/LLPIN
U51900MH1996PLC103901
- Company No.
103901
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Nov 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Alpha And Omega Medicals (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudha Berlia  | Director | 11-Nov-1996 | Current |
| Rajendrakumar Padia | Director | 18-Jul-2002 | Current |
| Rashmi Padia | Director | 05-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of Alpha And Omega Medicals (India).
Alpha And Omega Medicals (India) Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 20.57% decrease. The company also saw a substantial fall in profitability, with a 26.94% decrease in profit. The company's net worth Soared by an impressive increase of 13.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alpha And Omega Medicals (India)?
In 2019, Alpha And Omega Medicals (India) had a promoter holding of 99.20% and a public holding of 0.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alpha And Omega Diagnostics (India) LimitedActive 29 years 3 monthsSudha Berlia, Rajendrakumar Padia and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alpha And Omega Medicals (India)?
Unlock and access historical data on people associated with Alpha And Omega Medicals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alpha And Omega Medicals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alpha And Omega Medicals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
